IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v256y2020ics0277953620302549.html
   My bibliography  Save this article

Determinants of non-prescription antibiotic dispensing in Chinese community pharmacies from socio-ecological and health system perspectives

Author

Listed:
  • Wang, Xiaomin
  • Xuan, Ziming
  • Storella, Théo H.
  • Zhou, Xudong

Abstract

Although non-prescription antibiotic dispensing (NPAD) has been officially forbidden by the Chinese government since 2004, it is still a common practice throughout the country. In this study, we use China as an example to explore the determinants of NPAD within the framework of its health system from a socio-ecological perspective. A mixed-method combining the simulated client method (SCM) and key informant interviews conducted in Zhejiang, Hubei, and Sichuan provinces was adopted. 73.3% of the SCM interactions engendered NPAD (91.7% through antibiotic requests vs. 55% through consultation) in Chinese community pharmacies; a much higher rate than the global average. At the intrapersonal level, NPAD was found to be driven by profits from selling non-prescription antibiotics and traditional Chinese medicine. At the interpersonal level, NPAD was driven by fierce competition in the community pharmacy market and by customers' unreasonable expectations. At the institutional level, it is easy for community pharmacies to evade the Food and Drug Administration's (FDA) supervision by obtaining unsupervised and fake prescriptions, refusing to give customers sale receipts, and hiding their antibiotic supplies and sale records. At the policy level, the low cost of violating the prescription-only antibiotic sale regulation and poor FDA supervision facilitated NPAD. The Chinese health system has thus failed to establish and regulate a diverse network of pharmacies for patients to fill their prescriptions; few antibiotic prescriptions are transferred from hospitals to community pharmacies. Education campaigns to increase awareness about the risks of self-medication with antibiotics among the general public, recognizable standardize prescriptions for customers to fill their prescriptions in community pharmacies, regulations on Internet and private clinic doctors' antibiotic prescribing behaviors, electronic tracking and tracing system to purchases and sales data of antibiotics and other prescription drugs, increasing cost of violating the prescription-only regulations for antibiotics sales are expected interventions to reduce NPAD.

Suggested Citation

  • Wang, Xiaomin & Xuan, Ziming & Storella, Théo H. & Zhou, Xudong, 2020. "Determinants of non-prescription antibiotic dispensing in Chinese community pharmacies from socio-ecological and health system perspectives," Social Science & Medicine, Elsevier, vol. 256(C).
    • Handle: RePEc:eee:socmed:v:256:y:2020:i:c:s0277953620302549
    DOI: 10.1016/j.socscimed.2020.113035
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0277953620302549
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.socscimed.2020.113035?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Fu, Hongqiao & Li, Ling & Yip, Winnie, 2018. "Intended and unintended impacts of price changes for drugs and medical services: Evidence from China," Social Science & Medicine, Elsevier, vol. 211(C), pages 114-122.
    2. Imai, Hiroyuki, 2018. "China’s rapid growth and real exchange rate appreciation: Measuring the Balassa-Samuelson effect," Journal of Asian Economics, Elsevier, vol. 54(C), pages 39-52.
    3. Vaananen, Minna Heleena & Pietila, Kirsi & Airaksinen, Marja, 2006. "Self-medication with antibiotics--Does it really happen in Europe?," Health Policy, Elsevier, vol. 77(2), pages 166-171, July.
    4. Yu, Xuan & Li, Cheng & Shi, Yuhua & Yu, Min, 2010. "Pharmaceutical supply chain in China: Current issues and implications for health system reform," Health Policy, Elsevier, vol. 97(1), pages 8-15, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Shu Yan & Lizi Pan & Yan Lu & Juan Chen & Ting Zhang & Dongzi Xu & Zhaolian Ouyang, 2023. "Towards Sustainable Drug Supply in China: A Bibliometric Analysis of Drug Reform Policies," Sustainability, MDPI, vol. 15(13), pages 1-20, June.
    2. Liu, Kai & Zhang, Qian & He, Alex Jingwei, 2021. "The impacts of multiple healthcare reforms on catastrophic health spending for poor households in China," Social Science & Medicine, Elsevier, vol. 285(C).
    3. Couharde, Cécile & Delatte, Anne-Laure & Grekou, Carl & Mignon, Valérie & Morvillier, Florian, 2020. "Measuring the Balassa-Samuelson effect: A guidance note on the RPROD database," International Economics, Elsevier, vol. 161(C), pages 237-247.
    4. Donghui Yang & Yan Wang & Shue Mei, 2021. "How to balance online healthcare platforms and offline systems? A supply chain management perspective," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 42(2), pages 502-515, March.
    5. Väänänen, Minna Heleena & Lyles, Alan & Airaksinen, Marja, 2009. "The symptom mitigation path of mobile community residents: Community pharmacy's role," Health Policy, Elsevier, vol. 89(1), pages 14-25, January.
    6. Li, Mingqiang & Li, Zhihui & Yip, Chi-Man (Winnie), 2022. "Informal payments and patients’ perceptions of the physician agency problem: Evidence from rural China," Social Science & Medicine, Elsevier, vol. 298(C).
    7. Chen, Xu & Li, Shanshan & Wang, Xiaojun, 2020. "Evaluating the effects of quality regulations on the pharmaceutical supply chain," International Journal of Production Economics, Elsevier, vol. 230(C).
    8. Mengna Luan & Wenjing Shi & Zhigang Tao & Hongjie Yuan, 2023. "When patients have better insurance coverage in China: Provider incentives, costs, and quality of care," Economics of Transition and Institutional Change, John Wiley & Sons, vol. 31(4), pages 1073-1106, October.
    9. Jiménez-Rubio, Dolores & Hernández-Quevedo, Cristina, 2010. "Explaining the demand for pharmaceuticals in Spain: Are there differences in drug consumption between foreigners and the Spanish population?," Health Policy, Elsevier, vol. 97(2-3), pages 217-224, October.
    10. Felicia Robertson & Sverker C. Jagers & Björn Rönnerstrand, 2018. "Managing Sustainable Use of Antibiotics—The Role of Trust," Sustainability, MDPI, vol. 10(1), pages 1-13, January.
    11. Thomas Allen & Dorte Gyrd-Hansen & Søren Rud Kristensen & Anne Sophie Oxholm & Line Bjørnskov Pedersen & Mario Pezzino, 2022. "Physicians under Pressure: Evidence from Antibiotics Prescribing in England," Medical Decision Making, , vol. 42(3), pages 303-312, April.
    12. Marta Makowska & Rafał Boguszewski & Michał Nowakowski & Monika Podkowińska, 2020. "Self-Medication-Related Behaviors and Poland’s COVID-19 Lockdown," IJERPH, MDPI, vol. 17(22), pages 1-19, November.
    13. Fulai Gu & Xiaobing Liu & Lian Qi & Xiaowei Xu & Zheng Zeng, 2021. "Financial and social impacts of drug price changes: Evidence from 2017 healthcare reform in Liaoning Province, China," International Journal of Health Planning and Management, Wiley Blackwell, vol. 36(6), pages 2215-2230, November.
    14. Ying Yang & Huijing Wu & Caixia Yan, 2021. "Medical consumable usage control based on Canopy_K-means clustering and WARM," Journal of Combinatorial Optimization, Springer, vol. 42(4), pages 722-739, November.
    15. Currie, Janet & Lin, Wanchuan & Meng, Juanjuan, 2014. "Addressing antibiotic abuse in China: An experimental audit study," Journal of Development Economics, Elsevier, vol. 110(C), pages 39-51.
    16. Chen, Xu & Yang, Huan & Wang, Xiaojun, 2019. "Effects of price cap regulation on the pharmaceutical supply chain," Journal of Business Research, Elsevier, vol. 97(C), pages 281-290.
    17. Chin‐Yoong Wong & Yoke‐Kee Eng, 2022. "Renminbi Appreciation and China's Industrial Upgrading," China & World Economy, Institute of World Economics and Politics, Chinese Academy of Social Sciences, vol. 30(3), pages 1-22, May.
    18. Bahmani-Oskooee, Mohsen & Nouira, Ridha, 2021. "The nonlinear ARDL approach and productivity bias hypothesis: Evidence from 68 countries," The Quarterly Review of Economics and Finance, Elsevier, vol. 80(C), pages 80-89.
    19. Yu Xia & Jing Li & Zhongyang Zhang, 2023. "Effects of price cap regulation on pharmaceutical supply chain under the zero markup drug policy," Operational Research, Springer, vol. 23(4), pages 1-27, December.
    20. Ying Yang & Huijing Wu & Caixia Yan, 0. "Medical consumable usage control based on Canopy_K-means clustering and WARM," Journal of Combinatorial Optimization, Springer, vol. 0, pages 1-18.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:256:y:2020:i:c:s0277953620302549. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.